General Anesthesia exposure and neurodevelopmental outcome in Pediatrics.

General Anesthesia exposure and neurodevelopmental outcome in Pediatrics. - GAP trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54873

Enrollment

Registered

2020-01-13

Start date

2020-10-21

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain development Neurodevelopmental outcome

Interventions

None listed

Eligibility

Age

No minimum to 11 Years

Inclusion criteria

Inclusion criteria: - Infants aged 12 months - Anesthesia exposure before the age of 12 months

Exclusion criteria

Exclusion criteria: Children with comorbid conditions affecting structure and/or function of the central nervous system (e.g. premature birth) will be excluded from participation in this study.

Design outcomes

Primary

Measure	Time frame
Neurodevelopmental outcome (infant development, motor and cognitive development and early attention) in children with a history of anesthesia exposure before the age of 12 months.	—

Secondary

Measure	Time frame
Concurrent, convergent and divergent validity of eye-tracking relative to traditional measures (Ages & Stages Questionnaire and Bayley Scales of Infant Development) of neurodevelopmental outcome in children with a history of anesthesia exposure before the age of 12 months.	—

Countries

Netherlands

Outcome results